相关实验视频

Updated: Jun 4, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

设计,合成和活动评估C-23-修饰的5-O-Mycaminosyltylonolide衍生物

Zhengmin Fan^1,2,3, Ziwei Lin^1,2,3, Hongjin Zhai^1,2,3,4

¹School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, PR China.

ACS medicinal chemistry letters

|December 18, 2024

概括

新的泰洛辛衍生物可以对抗细菌耐药性. 化合物c9表现出强大的抗菌活性,对抗性细菌,如黄金葡萄球菌和大肠杆菌具有低毒性,提供一个有希望的新的抗菌.

科学领域:

药用化学医学化学
微生物学微生物学
药理学药理学是指药理学的学科.

背景情况:

广泛使用泰洛辛会导致细菌耐药性,降低药物的有效性.
宏类抗生素至关重要,但耐药性是一个越来越令人担忧的问题.
需要新的衍生品来克服现有的阻力机制.

研究的目的:

设计和合成新型半合成泰洛衍生物.
评估这些新化合物的抗菌活性和毒性.
确定一种潜在的化合物,用于开发新的宏类抗生素.

主要方法:

合成的泰洛辛衍生物在C-23位置有修改.
对包括耐药菌株在内的格拉姆阴性和格拉姆阳性细菌进行了抗菌活性测试.
在体外和体内生物中评估化合物毒性.
确定了最小抑制度 (MIC) 和杀菌功效.

主要成果:

一些合成的化合物表现出显著的抗菌活性.
化合物c9对黄金葡萄球菌和大肠杆菌表现出强烈的活性 (MIC=0.5ug/mL).
化合物c9显示出优异的杀菌效果,低耐药性诱导,以及对耐药细菌的良好活性.
化合物c9在体外和体外表现出低毒性.

结论:

化合物c9是一种非常有前途的抗微生物.
这种衍生物可以促进新型宏类抗生素的开发.
修改C-23的策略是有效的创建新的抗菌剂.

更多相关视频

Sequence-specific Labeling of Nucleic Acids and Proteins with Methyltransferases and Cofactor Analogues

Sequence-specific Labeling of Nucleic Acids and Proteins with Methyltransferases and Cofactor Analogues

Published on: November 22, 2014

Solid-phase Synthesis of [4.4] Spirocyclic Oximes

Solid-phase Synthesis of [4.4] Spirocyclic Oximes

Published on: February 6, 2019

相关概念视频

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...